Binding of glyceraldehyde-3-phosphate dehydrogenase to the cis-acting element of structure-anchored repression in ccn2 mRNA

Biochemical and Biophysical Research Communications

Volumn 405, Issue 3, 2011, Pages 382-387

  Kondo, Seiji ^a,b   Kubota, Satoshi ^b   Mukudai, Yoshiki ^a,c   Nishida, Takashi ^b   Yoshihama, Yasuto ^a   Shirota, Tatsuo ^a   Shintani, Satoru ^a   Takigawa, Masaharu ^b,c  

^a SHOWA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

3' UTR; CCN2; GAPDH; Hypoxia; MRNA stability

Indexed keywords

CIS ACTING ELEMENT; CONNECTIVE TISSUE GROWTH FACTOR; DIAMIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; MERCAPTOETHANOL; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; COENZYME; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME BINDING; ENZYME METABOLISM; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; MASS SPECTROMETRY; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; REDOX STRESS; RNA BINDING; RNA STRUCTURE; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; CELL HYPOXIA; CELL LINE, TUMOR; CONNECTIVE TISSUE GROWTH FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HUMANS; NAD; NEOVASCULARIZATION, PATHOLOGIC; OXIDANTS; OXIDATIVE STRESS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 79951580936     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.034     Document Type: Article

References (38)

1. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
2. Warburg O. On the origin of cancer cells. Science 1956, 55:836-839.
3. Kondoh H., LIeonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65:177-185.
4. Xu R.-H., Pelicano H., Zhou Y., Carew J.S., Feng L., Bhalla K.N., Keating M.J., Huang P. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005, 65:613-621.
5. Dang C.V., Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 1999, 24:68-72.
6. Singh R., Green M.R. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 1993, 259:365-368.
7. Nagy E., Rigby W.F.C. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD+-binding region (Rossmann Fold). J. Biol. Chem. 1995, 270:2755-2763.
8. Nagy E., Henics T., Eckert M., Miseta A., Lightowlers R.N., Kellermayer M. Identification of the NAD+-binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain. Biochem. Biophys. Res. Commun. 2000, 275:253-260.
9. Arutyunova E.I., Danshina P.V., Domnina L.V., Pleten A.P., Muronetz VI. Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids. Biochem. Biophys. Res. Commun. 2003, 307:547-552.
10. Pioli P.A., Hamilton B.J., Connolly J.E., Brewer G., Rigby W.F.C. Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1. J. Biol. Chem. 2002, 277:35738-35745.
11. Elzinga S.D., Bednarz A.L., Oosterum K.V., Dekker P.J., Grivell L.A. Yeast mitochondrial NAD(+)-dependent isocitrate dehydrogenase is an RNA-binding protein. Nucleic Acids Res. 1993, 21:5328-5331.
12. Chu E., Koeller D.M., Drake J.C., Takimot J.C., Maley G., Maley F., Allegra C.J. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA 1991, 88:8977-8981.
13. Chu E., Takimoto C.H., Voeller D., Grem J.L., Allegra C.J. Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro. Biochemistry 1993, 32:4756-4760.
14. Nakagawa J., Waldner H., Meyer-Monard S., Hofsteenge J., Jenö P. AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc. Natl. Acad. Sci. USA 1995, 92:2051-2055.
15. Nanbu R., Kubo T., Hashimoto T., Natori S. Purification of an AU-rich RNA binding protein from Sarcophaga peregrina (flesh fly) and its identification as a thiolase. J. Biochem. 1993, 114:432-437.
16. Bonafé N., Gilmore-Hebert M., Folk N.L., Azodi M., Zhou Y., Chambers S.K. Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Res. 2005, 65:3762-3771.
17. Zhou Y., Yi X., Stoffer J.B., Bonafe N., Gilmore-Hebert M., McAlpine J., Chambers S.K. The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer. Mol. Cancer Res. 2008, 6:1375-1384.
18. Takigawa M., Nakanishi T., Kubota S., Nishida T. Role of CTGF/HCS24/ecogenin in skeletal growth control. J. Cell. Physiol. 2003, 194:256-266.
19. Kubota S., Takigawa M. Role of CCN2/CTGF/Hcs24 in bone growth. Int. Rev. Cytol. 2007, 257:1-41.
20. Shimo T., Nakanishi T., Nishida T., Asano M., Sasaki A., Kanyama M., Kuboki T., Matsumura T., Takigawa M. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 2001, 61:315-322.
21. Shimo T., Kubota S., Yoshioka N., Ibaragi S., Isowa S., Eguchi T., Sasaki A., Takigawa M. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J. Bone Miner. Res. 2006, 21:1045-1059.
22. Kondo S., Kubota S., Shimo T., Nishida T., Yosimichi G., Eguchi T., Sugahara T., Takigawa M. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002, 23:769-776.
23. Eguchi T., Kubota S., Kondo S., Shimo T., Hattori T., Nakanishi T., Kuboki T., Yatani H., Takigawa M. Regulatory mechanism of human connective tissue growth factor (CTGF/Hcs24) gene expression in a human chondrocytic cell line HCS-2/8. J. Biochem. 2001, 130:79-87.
24. Eguchi T., Kubota S., Kondo S., Kuboki T., Yatani H., Takigawa M. A novel cis-element that enhances connective tissue growth factor gene expression in chondrocytic cells. Biochem. Biophys. Res. Commun. 2002, 395:445-451.
25. Higgins D.F., Biju M.P., Akai Y., Wutz A., Johnson R.S., Haase V.H. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Physiol. Renal. Physiol. 2004, 287:1223-1232.
26. Kondo S., Kubota S., Eguchi T., Hattori T., Nakanishi T., Sugahara T., Takigawa M. Characterization of a mouse ctgf 3'-UTR segment that mediates repressive regulation of gene expression. Biochem. Biophys. Res. Commun. 2000, 278:119-124.
27. Kubota S., Hattori T., Nakanishi T., Takigawa M. Involvement of cis-acting repressive element(s) in the 3'-untranslated region of human connective tissue growth factor gene. FEBS Lett. 1999, 450:84-88.
28. Kubota S., Kondo S., Eguchi T., Hattori T., Nakanishi T., Pomerantz R.J., Takigawa M. Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: similarities to retroviral RNA-protein interactions. Oncogene 2000, 19:4773-4786.
29. Mukudai Y., Kubota S., Takanori E., Kondo S., Nakao K., Takigawa M. Regulation of chicken ccn2 gene by interaction between RNA cis-element and putative trans-factor during differentiation of chondrocytes. J. Biol. Chem. 2005, 280:3166-3177.
30. Mukudai Y., Kubota S., Kawaki H., Kondo S., Eguchi T., Sumiyoshi K., Ohgawara T., Shimo T., Takigawa M. Posttranscriptional regulation of chicken ccn2 gene expression by nucleophosmin/B23 during chondrocyte differentiation. Mol. Cell. Biol. 2008, 28:6134-6147.
31. Kubota S., Mukudai Y., Moritani N.H., Nakao K., Kawata K., Takigawa M. Translational repression by the cis-acting element of structure-anchored repression (CAESAR) of human ctgf/ccn2 mRNA. FEBS Lett. 2005, 579:3751-3758.
32. Kondo S., Kubota S., Mukudai Y., Moritani N.H., Nishida T., Matsushita H., Matsumoto S., Sugahara T., Takigawa M. Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3'-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene 2006, 25:1099-1110.
33. Takigawa M., Tajima K., Pan H.O., Enomoto M., Kinoshita A., Suzuki F., Takano Y., Mori Y. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res. 1989, 49:3996-4002.
34. Zhang W., Wagner B.J., Ehrenman K., Schaefer A.W., DeMaria C.T., Crater D., DeHaven K., Long L., Brewer G. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 1993, 13:7652-7665.
35. Myer V.E., Fan X.C., Steitz J.A. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 1997, 16:2130-2139.
36. Levine T.D., Gao F., King P.H., Andrews L.G., Keene J.D. Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 1993, 13:3494-3504.
37. Hamilton B.J., Nagy E., Malter J.S., Arrick B.A., Rigby W.F. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J. Biol. Chem. 1993, 268:8881-8887.
38. Rondon I.J., Scandurro A.B., Wilson R.B., Beckman B.S. Changes in redox affect the activity of erythropoietin RNA binding protein. FEBS Lett. 1995, 359:267-270.